Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Pin to quick picksCLIN.L Share News (CLIN)

  • There is currently no data for CLIN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Shares in Clinigen surge on takeover talks with Triton Investment

Thu, 02nd Dec 2021 14:28

(Alliance News) - Clinigen Group PLC's shares surged on Thursday after the company confirmed that it is in takeover discussions with Triton Investment Management Ltd.

Shares in the Staffordshire-based pharmaceuticals and services provider were 18% higher at 746.50 pence on Thursday afternoon in London, giving the company a market cap of GBP797.5 million.

The pharmaceutical company said it was in "advanced discussions" with the London-based investment firm and made the announcement without the consent of Triton.

The company added that there can be "no certainty" that any firm offer will be made nor on the terms on which any firm offer might be made.

Triton is required to announce its decision on an offer for the company by no later than 1700 GMT on December 30.

By Heather Rydings; heatherrydings@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
8 Dec 2021 08:16

Clinigen to be taken private by Triton in £1.2bn deal, shares surge

(Sharecast News) - Clinigen surged on Wednesday after agreeing to be taken private by European investment firm Triton in a £1.2bn deal.

Read more
2 Dec 2021 12:59

Clinigen confirms takeover talks with Triton, shares surge

(Sharecast News) - Clinigen shares surged on Thursday after the company confirmed it has received a non-binding indicative proposal from investment firm Triton about a possible offer.

Read more
2 Dec 2021 09:52

LONDON BROKER RATINGS: Upgrades for Old Mutual and Superdry; Drax cut

LONDON BROKER RATINGS: Upgrades for Old Mutual and Superdry; Drax cut

Read more
1 Dec 2021 13:42

Clinigen's leukaemia treatment Erwinase fails to gain approval in US

Clinigen's leukaemia treatment Erwinase fails to gain approval in US

Read more
29 Nov 2021 11:21

Clinigen signs exclusive agreement with Nippon Shinyaku on Viltepso

Clinigen signs exclusive agreement with Nippon Shinyaku on Viltepso

Read more
25 Nov 2021 16:01

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
17 Nov 2021 16:01

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
5 Nov 2021 09:55

Liberum lowers target price on Clinigen

(Sharecast News) - Analysts at Liberum lowered their target price on pharmaceutical services and products group Clinigen from 886.0p to 800.0p on Friday but stated risks still appeared to be "skewed to the upside".

Read more
8 Oct 2021 08:46

Clinigen and Humanigen partner to progress investigational Covid drug

Clinigen and Humanigen partner to progress investigational Covid drug

Read more
22 Sep 2021 19:31

TRADING UPDATES: Clinigen signs Copiktra deal; Alien "really pleased"

TRADING UPDATES: Clinigen signs Copiktra deal; Alien "really pleased"

Read more
22 Sep 2021 13:34

Clinigen to distribute 'Copiktra' in most of Europe

(Sharecast News) - Pharmaceutical products and services provider Clinigen has signed an exclusive agreement with Secura Bio for the supply and distribution of 'Copiktra' in most of Europe, it announced on Wednesday.

Read more
16 Sep 2021 12:29

Clinigen cuts full-year earnings forecasts, shares fall

(Sharecast News) - Shares in Clinigen Group fell on Thursday after the pharmaceuticals specialist cut its full-year earnings forecast.

Read more
16 Sep 2021 12:07

Clinigen shares fall on lowered outlook as profit more than doubles

Clinigen shares fall on lowered outlook as profit more than doubles

Read more
16 Sep 2021 10:55

AIM WINNERS & LOSERS: Kibo invests in Eqtec project; Clinigen falls

AIM WINNERS & LOSERS: Kibo invests in Eqtec project; Clinigen falls

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.